TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

TELIX PHARMACEUTICALS INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Telix Stockholders of the Ongoing Investigation

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Bragar Eagel & Squire, P.C.
TELIX PHARMACEUTICALS INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Telix Stockholders of the Ongoing Investigation

Law firm investigating potential securities law violations by Telix Pharmaceuticals after receiving an SEC subpoena, which caused the company's ADR price to drop 10.44%.

Insights
TLX   negative

Company received an SEC subpoena seeking documents about its prostate cancer therapeutic candidates, which triggered a 10.44% stock price decline and prompted a legal investigation into potential securities law violations